Details
Category: Volume 09 Issue 06 June 2021
Hits: 775

Title: Assessment of Acute Toxicity Profile of Hypo-Fractionated Radiotherapy in Locally Advanced Breast Cancer

Authors: Hemendra Mishra, Simrandeep Singh, Tarun Kumar, K. T. Bhowmik, Kapil Suri, Rajiv Sharma, Jaspreet Kaur, Vikas Yadav, Vikas Madholia, Akhilesh Mishra, Rajesh Sethi, Biju Azariah, Ratika Gupta

 DOI: https://dx.doi.org/10.18535/jmscr/v9i6.28

Abstract

Introduction

Breast cancer is the second most common cancer in the world and, by far, the most frequent cancer among women with an estimated 1.67 million new cancer cases diagnosed in 2012 (25% of all cancers).1 It is the most common cancer in women both in developed and developing regions with slightly more cases in developed regions than in developing regions. Incidence rates vary nearly four-fold across the world regions, with rates ranging from 27 per 100,000 in Middle Africa and Eastern Asia to 92per 100,000 in Northern America.2 In India, breast cancer was estimated to cause 6.1 deaths per 100,000 population in the year 2016. The survival rate decreased by 2.7 times for breast cancer, in case of detection at stage IV as against stage I. A total of 80,700 women died of cancer breast in 2016 in India.3

References

  1. Latest world cancer statistics – GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. 12 December 2013
  2. Ferlay, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008. Globocan International journal of Cancer 2008; 127: 2893-2917.
  3. WHO Bulletin (2018), Global Health Estimates 2016, Cancer, April2018.
  4. Valero VV, Buzdar AU, Hortobagyi GN. Locally advanced breast cancer. Oncologist 1996;1:8-17.
  5. Rakesh Chopra. The Indian scene of breast cancer. Journal of Clinical Oncology 2001;19:106-111 .
  6. American College of Radiology. ACR Appropriateness Criteria®: postmastectomy radiotherapy. 2015:6.
  7. Whelan TJ, Pignol JP, Levine MN, Julian JA, MacKenzie R, Parpia S, et al. Long- term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010;362(6):513-20.
  8. Owen JR, Ashton A, Bliss JM, Homewood J, Harper C, Hanson J, et al. Effect of radiotherapy fraction size on tumor control in patients with early stage breast cancer after local tumor excision: long-term results of a randomized trial. Lancet Oncol 2006;7(6):467-71.
  9. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss J Metal. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. The Lancet. Oncology. 2008Apr;9(4):331-41.
  10. Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bliss JM, etal. The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet (London, England). 2008;371 (9618):1098-1107.
  11. Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomized controlled trials. The lancet oncology. 2013Oct1;14(11):1086-94.
  12. Adjuvant post mastectomy hypofractionated Radiotherapy in Egyptian cancer patients. Annals of Oncology 2012;23:34-36.
  13. Boyle P, Ferday J. Epidemiology of breast cancer. Bailliere S Clinical Oncology 1988;2:1 -57.
  14. Thames HD, Bentzen SM, Turesson I, Overgaard M, Van den Bogaert W. Time- dose factors in radiotherapy a review of human data. Radiotherapy and Oncology 1990;19:219-235.
  15. Cox JD et al. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995 Mar 30;31(5):1341-6.
  16. Bhattacharyya M, Kalita AK, Medhi PP, Jagtap V, Sunku R, Hassan FA, et al. Hypofractionated radiotherapy in post mastectomy locally advanced breast cancer: a study from a regional cancer center in North East India. Int J Res Med Sci 2018;6:3942-8.
  17. Mishra R, Khurana R, Mishra H, Rastogi M, Hadi R Retrospective Analysis of Efficacy and Toxicity of Hypo-fractionated Radiotherapy in Breast Carcinoma Journal of Clinical and Diagnostic Research. 2016 Aug, Vol-10(8):XC01-XC032
  18. El-Sayed MI, Abdel-Wanis ME Comparison of hypofractionated and conventional radiotherapy protocols in breast cancer patients: a retrospective study. J Cancer Sci Ther.2012;4:158-63.
  19. Gogia A, Raina V, Deo SV, Shukla NK, Mohanti BK, Sharma DN, Taxane and anthracycline Based Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer : Institutional Experience; Asian Pacific Journal of Cancer Prevention, 2014:15 (5):1989-1992
  20. Hopwood P, Haviland JS, Sumo G, Mills J, Bliss JM, et al. (2010) Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardization of Breast Radiotherapy (START) trials. Lancet Oncol 11:231-240.
  21. Abhilash G. H, Anil Kumar Dhull, Rajeev Atri, Rakesh Dhankhar, Vivek Kaushal Comparison of hypofractionated radiation therapy versus conventional radiation therapy in post mastectomy breast cancer. Journal of Evidence Based Medicine and Healthcare, 2016 (26):1177-81

Corresponding Author

Tarun Kumar

Senior Resident, Department of Radiotherapy, VMMC & Safdarjung Hospital, New Delhi, India